Abstract
Solid dispersions (SDs) of the poorly water soluble antidiabetic drug, glibenclamide(GLB), were prepared using polyethylene glycol 4000(PEG) through the fusion and solvent-fusion method. Solid-state analysis and the in vitro drug release profiles of the prepared formulations were assessed. Compressibility and flowability of the prepared solid dispersions were also evaluated. The dissolution rate of the prepared SDs was greatly superior to GLB. The release profile was more dependent on drug to hydrophilic polymer ratio than the preparation technique. The FTIR studies showed no interaction between drug and polymer. DSC thermograms of the prepared SDs showed no endothermic peak of GLB, which could be attributed to the gradual dissolving of the GLB in the melted PEG and/or drug amorphization. Moreover, prepared SDs were showed superior compressibility and flowability. According to the obtained results, GLB/PEG SDs both prepared successfully by fusion and solvent-fusion technique and showed improved flowability and dissolution. This will likely lead to an increase in drug bioavailability and glucose control performance in diabetic patients. There was no significant difference between the obtained result from fusion and solvent-fusion method. However, due to the lack of organic solvent as well as simple and economical manufacturing process fusion method is more reasonable.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.